To systematically identify genes that maintain genome structure, yeast knockout mutants were examined by using three assays that followed marker inheritance in different chromosomal contexts. These screens identified 130 null mutant strains exhibiting chromosome instability (CIN) phenotypes. Differences in both phenotype severity and assay specificity were observed. The results demonstrate the advantages of using complementary assays to comprehensively identify genome maintenance determinants. Genome structure was important in determining the spectrum of gene and pathway mutations causing a chromosome instability phenotype. Protein similarity identified homologues in other species, including human genes with relevance to cancer. This extensive genome instability catalog can be combined with emerging genetic interaction data from yeast to support the identification of candidate targets for therapeutic elimination of chromosomally unstable cancer cells by selective cell killing.
To systematically identify genes that maintain genome structure, yeast knockout mutants were examined by using three assays that followed marker inheritance in different chromosomal contexts. These screens identified 130 null mutant strains exhibiting chromosome instability (CIN) phenotypes. Differences in both phenotype severity and assay specificity were observed. The results demonstrate the advantages of using complementary assays to comprehensively identify genome maintenance determinants. Genome structure was important in determining the spectrum of gene and pathway mutations causing a chromosome instability phenotype. Protein similarity identified homologues in other species, including human genes with relevance to cancer. This extensive genome instability catalog can be combined with emerging genetic interaction data from yeast to support the identification of candidate targets for therapeutic elimination of chromosomally unstable cancer cells by selective cell killing. C hanges in genome structure underlie many human disease states, and an important example is cancer. Changes in chromosome number or structure are commonly observed in tumors (1, 2) and many cancer cells exhibit aberrant cell architecture, including abnormal centrosomes, multipolar spindles, and breakage-fusionbridge cycles (3, 4) . Furthermore, mutations in or misregulation of genes involved in DNA damage recognition and repair, the mitotic spindle checkpoint, or proper chromosome transmission (1, (5) (6) (7) (8) (9) is associated with cancer development (10, 11) . Genomic instability can occur early during tumorigenesis (10, 12, 13) and promotes both tumor progression and heterogeneity (14) . Whether genomic instability reflects cause or effect of altered cell physiology during tumorigenesis, a comprehensive identification of genes whose mutation leads to chromosome instability [referred to as CIN genes (10) ] is an important, but daunting, goal yet to be achieved. Understanding the etiology of genome instability in viable cells is fundamental to understanding the development and survival of cancers and may be instrumental in the design of therapeutic approaches that take advantage of specific vulnerabilities exhibited by cancer cells. For highly conserved biological pathways such as genome maintenance, results from model organisms can greatly facilitate functional discovery in humans.
Phenotype screening based on marker stability in budding yeast has provided a powerful approach for studying genes that act to preserve genome structure (15) (16) (17) (18) (19) (20) (21) (22) , and these genes are often functionally conserved in other eukaryotes. Genetic screens by random mutagenesis have led to identification of gene sets important for various steps in the chromosome cycle, including those functioning at kinetochores, telomeres, and origins of replication, or in microtubule dynamics, sister chromatid cohesion, DNA replication, repair, condensation and cell cycle checkpoints. All these processes must be executed at high fidelity to maintain genetic integrity. However, the random mutagenesis approach rarely achieves screen saturation because mutability varies among genes because of differences in size, base composition, and the frequency of mutable sites that can lead to viable cells with a detectable phenotype. However, the use of the gene knockout collection for Saccharomyces cerevisiae supports new and powerful strategies based on direct phenotyping of null mutants. The Ϸ4,700 nonessential gene-deletion mutants represent Ͼ70% of yeast genes, 30% of which remain functionally unclassified (23, 24) (Saccharomyces Genome Database (SGD); www.yeastgenome.org).
In this study, we have used the gene knockout set to carry out three systematic screens to identify genes important for maintaining genome stability in yeast (i.e., nonessential yeast CIN genes). In addition to extending the catalog of genes known to affect genome structure, several themes emerged. Because all mutants characterized are null, phenotype strength reflects the magnitude of the role played by each gene in genome stability. Thus, direct comparisons are meaningful, between different mutants in a given assay system or between different assay systems for a given mutant. We observed that some mutants exhibit phenotypes that are screen-specific. This result confirms the idea that structural context in the genome determines what pathways predominate in protecting against genomic change. Also, protein similarity searches were used to identify candidate CIN homologues in other species, including human genes with relevance to cancer. We specifically discuss a strategy that uses both the yeast CIN gene catalog and emerging yeast genetic interaction data to identify ''common nodes'' in synthetic lethal interaction networks based on yeast CIN genes whose human counterparts are mutated in cancers. Human homologs of these common nodes may be useful as drug targets with broad spectrum applicability for selective elimination of genomically unstable cancer cells.
the MATa and MAT␣ loci in homozygous diploid deletion mutants. Diploid cells heterozygous at MAT do not mate due to codominant suppression of haploid-specific cell differentiation pathways. Loss of either MATa or MAT␣ allele results in mating competence, where mating type is determined by the remaining allele. Reciprocal mating tests with MATa or MAT␣ mating testers were performed on the homozygous diploid deletion set to identify those which form mated products at high rates. The endogenous rate of loss of either MAT allele in wild-type cells is two to four events in 10 5 divisions (18, 32) , where the predominant mechanism is mitotic recombination between homologs. Loss of heterozygosity in this assay can also be due to chromosome loss, chromosomal rearrangement (deletions or translocations with loss), or gene conversion (allele replacement).
In the third screen [designated a-like faker (ALF); Fig. 1c ], the MAT␣ locus inheritance was similarly followed by a mating test, but performed by using the MAT␣ haploid deletion set. The MAT␣ locus encodes transcription factors that suppress a-specific and promote ␣-specific gene expression (33) . Loss of the MAT␣ locus leads to the default mating type in yeast, which is the a-type differentiation state. Thus, MAT␣ cells that lose the MAT locus will mate as a-type cells and are called ''a-like fakers'' (ALFs) (33) . The frequency of ALF cells in a population is detected by prototrophic selection of mated products. In wild-type yeast, ALF mitotic segregants are generated at a rate of Ϸ10 Ϫ6 (34, 35) ; C.D.W. and F.A.S., unpublished results). Mechanisms leading to ALF cells include whole chromosome loss, MAT allele disruption by chromosomal rearrangement, and gene conversion from the silent mating type locus HMRa. The relative frequencies of these events in wild-type cells are reported below.
The mutants identified in the three assays were subjected to additional validations. First, positive mutations from each primary screen were retested in knockout strains for all three assays to establish phenotype reproducibility. Three hundred ten knockout mutations were identified after secondary screening (84 CTF, 130 BiM, and 247 ALF strains). Next, the effect of cross-well contamination was evaluated by determining the identity of the knockout mutations present in each of the 310 well locations in each of the three deletion arrays [details are in supporting information (SI) Tables 3 and 4 ]. This validation was accomplished by sequencing the oligonucleotide ''tag'' unique to each deletion allele (24) . The presence of Ͼ1 tag sequence or an incorrect tag sequence indicated well contamination, and the phenotypes of these locations were discarded. (The 310 well positions exhibited 22%, 9%, and 14% error in the MATa, MAT␣, and homozygous diploid sets, respectively). After adjustment, 293 knockout strains were verified as exhibiting CIN in at least one of the three assays. Of these 293 knockout strains, 210 (72%) were uncontaminated in all three sets. To investigate the overall error rate in each deletion set used, we sequenced strains from 60 randomly chosen well addresses and found 12%, 3%, and 3% contaminated wells in MATa, MAT␣, and homozygous diploid sets, respectively. The higher well contamination rate among yeast CIN mutants may reflect a high representation of slow growing yeast strains readily replaced by faster growing contaminants. An additional source of error in deletion collection phenotyping is the occasional presence of undesired ''secondary'' mutations that cause the phenotype being screened; that is, mutations that are not at the site of the knockout allele. Giaever et al. (24) estimate the presence of lethal or slow-growth phenotypes caused by mutations in genes that do not segregate with a knockout allele to occur at a frequency of 6.5%. To estimate the prevalence of secondary CIN mutations, subsets of knockout mutants were regenerated by independent transformation and phenotyped. Knockout mutations identified with phenotypes in at least two screens were reconfirmed as CIN mutants in new transformants at a high rate (13/13 CTF, 9/10 BiM, 9/11 ALF). On the other hand, mutants identified with phenotypes in a single assay were reconfirmed in new transformants at a lower rate, Ϸ43% for the haploid collections (2/6 of mutants exhibiting CTF only, 4/8 of mutants with ALF phenotype only), and Ϸ75% for the diploid collection (3/4 of mutants exhibiting BiM phenotype only). These data indicate a significant frequency of secondary mutation effects in the assay-specific subsets of CIN mutants identified in the primary screens, and emphasize the validation inherent in performing screens in multiple collections. The higher reconfirmation rate of BiM from the homozygous deletion mutants is consistent with the presence of secondary mutations, which would often be covered by the wild-type allele during the construction of diploids when independent haploid segregants were mated.
In total, 130 mutants are of high confidence (the 115 deletion strains identified in more than one assay, together with 15 mutants reconfirmed independently). These 130 are listed in Fig. 2 and SI Table 3 , which reflect current status of the data including all confirmations performed to date. The remaining 163 mutants identified in only one screen are listed in SI Table 4 . These 163 are regarded with lower confidence, containing an estimated Ϸ43% and Ϸ75% of true positives for haploid and diploid mutant screens, respectively. SI Tables 3 and 4 report measures of phenotype severity, as well as annotations for well contamination in any of the 3 deletion sets. It is important to note that the error rates described relate to the specific copies of the MATa, MAT␣, and MATa/ MAT␣ deletion collections that were obtained by our laboratories from commercial distribution sources. In addition to our manipulations, these collections are related to the original consortium collections by an unknown sequence of replication and outgrowth steps. containing a chromosome fragment (CF, blue line whose centromere is depicted as a circle) and ade2-101 were generated. Red colony color is caused by accumulation of pigment because of a block in adenine production caused by the ade2-101 (ochre) mutation. This block is relieved in the presence of the SUP11 gene (blue rectangle) located on the telocentric arm of the CF, encoding an ochre-suppressing tRNA Tyr . Cells that contain the CF are therefore unpigmented, whereas cells that lose the CF develop red color (27) (28) (29) . Colonies exhibiting unstable inheritance of this CF develop red sectors. (b) Homozygous diploid yeast knockout mutants were tested for bimater phenotype. For example, loss of the MATa allele (depicted in gray, Left) causes the development of an ␣-type mating cell, which is detected by its ability to mate with a MATa tester strain containing complementing auxotrophy to support selection of mated diploids. Mutant strains exhibiting unstable inheritance of the MAT locus will lose either allele in individual cell and exhibit a bimater phenotype in a population. The mutants in the squares show elevated formation of mated cells when exposed to either MAT␣ or MATa testers (18) . (c) MAT␣ haploid yeast knockout mutants were tested for elevated frequency of ALF cells. Loss of the MAT␣ locus in haploids results in dedifferentiation to a-mating type. The presence of these cells is detected by selection for mated products after exposure to a MAT␣ tester strain.
Functional Distribution of Yeast CIN Genes. Gene Ontology (GO) annotations among these 293 CIN genes in comparison to the entire yeast genome (36) indicated enrichment in numerous expected cellular components: nucleus, chromosome, kinetochore, microtubule, cytoskeleton, spindle, nuclear pore, spindle pole body, replication fork, and chromatin (SI Table 5 ). The CIN gene list is enriched in the GO biological processes of cell cycle, cell proliferation, response to DNA damage response, and nuclear division (SI Table 6 ). These GO annotations reflect current knowledge of studied genes, indicating that the screens identified genes known to be functioning in genome maintenance. Interestingly, genes not previously known to contribute to stability were also identified. For example, seven yeast mutants in the adenine biosynthetic pathway (ade1, ade2, ade4, ade5/7, ade6, ade8, and ade17) gave rise to elevated ALFs at frequencies ranging from 2-to 31-fold above wild-type (SI Tables 3 and 4) . Three of these mutants (ade1, ade6, and ade17 shown in Fig. 2 ) were validated in fresh transformants. This results indicates that cellular adenine pathway intermediates, or derivative metabolites, are important for genome stability, and that compensatory mechanisms used by cells when de novo synthesis is blocked are not fully sufficient. In addition, several CIN genes identified in the screens were recently characterized to play a role in genomic stability. Examples are Dia2 [an F-box protein in the SCF E3 ubiquitin ligase complex (37, 38) ], Nce4 [which associates with the Sgs1-Top3 helicase-topoimerase complex (39, 40) ], and Mms22 [which functions with Mms1 in a DNA damage repair pathway (41)]. Integrating the CIN gene catalog with other phenotypic, genetic, and physical interaction data available in yeast proves to be a fruitful avenue to further our understanding in mechanisms for genomic stability.
Chromosome Loss Is the Major Mechanism of MAT␣ Loss in a-Like
Fakers. The CTF and BiM phenotypes have been widely used to study genome instability. However, the ALF phenotype has been only rarely used (32, 42, 43) and has not been well characterized. The electrophoretic karyotype of mated colonies obtained after selection can be analyzed to infer the mechanism of MAT␣ locus loss. The chromosome III in the mating tester was visually differentiated from that in knockout strains by pulsed-field gel electrophoresis (Fig. 3A) . Hybridization with a probe that bound 3 distant sites on chromosome III (the MAT locus, and silent cassettes located distally on each arm) allowed detection of the two parental chromosome III bands as well as aberrant chromosome III derivatives. Aberrant chromosomes were observed in a variety of sizes. These chromosomes included an expected 200 kb product likely to represent homologous recombination between MAT␣ and silent locus HMRa. This event is known to generate an active MATa locus concomitant with a large deletion on the right arm of chromosome III (reviewed in ref. 35) .
Electrophoretic karyotypes of mated products from wild-type cells indicated that 68% of events were due to whole chromosome loss, 20% to chromosomal rearrangement, and 12% to gene conversion (Table 1) . We analyzed independent mated colonies for 13 high-frequency ALF mutants. In 11, loss of whole chromosome III was the predominant event, similar to wild-type. Statistically significant exceptions were observed for rad27⌬ and sov1⌬, which showed predominant chromosome rearrangement or an intact chromosome III, respectively. RAD27 encodes an endonuclease that promotes Okazaki fragment maturation during DNA replication. The ALF-associated rearrangements are consistent with previous observation that RAD27 protects against gross chromosomal Table 4 ). All gene names are connected to one or more of the three major nodes, indicating the screen phenotypes for which each knockout was positive (CTF, BiM, or ALF). Gene names in black typeface are those validated in all three deletion arrays: i.e., tag sequencing indicated the presence of the correct mutation in uncontaminated form. For these mutants, present and absent phenotypes are meaningful. Gene names in blue italic typeface failed tag validation in at least one of the deletion collections, and therefore phenotype information is missing from at least one screen. These partially characterized genes are placed to indicate observed tag-sequence validated phenotypes (SI Table 3 contains details). The node colors indicate biological process. Genes associated with more than one biological process are represented by the one highest in the color key for simplicity. Fig. 3 . A-like fakers result from whole chromosome loss, gross chromosomal rearrangement, and gene conversion. (A) Electrophoretic karyotypes of ALF mated products were examined for chromosome III status as described (42) , and examples are shown. Individual colonies selected after mating were characterized by using pulsed-field gel electrophoresis (top, ethidium bromide stained gel) and in-gel hybridization with a radiolabeled probe (bottom, autoradiogram) that hybridizes chromosomal bands containing the mating type locus and/or silent mating type loci located distally on each arm. Chromosomes III from the mating tester and deletion mutant were of distinct size (top and bottom chr III bands, respectively). In some strains, a less intense signal for rearrangement chromosomes reflects poor mitotic transmission, or hybridization only to HMRa which has imperfect homology to the radiolabeled probe. (B) Discordant CTF sectoring phenotypes are observed in knockout mutations with similar ALF frequencies.
rearrangements (44) . SOV1 is a reserved name (SGD) for a nuclear gene important for respiration whose encoded protein may localize to mitochondria from high-throughput studies (45) . Its gene conversion phenotype was unusual. To further define the events giving rise to ALFs, PCR was used to detect the presence of MATa and MAT␣ loci in the mated products (46) . Interestingly, all mated products from the sov1⌬ mutant contained both MATa and MAT␣ loci, indicating introduction of the MATa allele into MAT by gene conversion. This was not the general pattern observed in wild-type or in other mutants, where only 3% (1/39) or 6% (24/386) of isolates tested were of this type, respectively.
Interestingly, some high-frequency ALFs that showed whole chromosome III loss failed to exhibit a sectoring phenotype in the CTF screen. Of 13 frequent ALF mutants analyzed in Fig. 3 , only 5 were identified for CTF phenotypes by the high throughput screen: 3 with strong (kar3⌬, sic1⌬, and dia2⌬) and 2 with weak (rad27⌬, nce4⌬) phenotypes. To confirm the presence of assay difference, 5 frequent ALF mutants were directly retested for the CTF phenotype in fresh transformants. Two of these mutants (kar3⌬, sic1⌬) exhibited a strong CTF phenotype as expected, and 3 were confirmed to show mild or absent sectoring (esc2⌬, rad50⌬, xrs2⌬; Fig. 3B ). Thus, frequent ALF production does not strictly correlate with frequent CF loss. This result may indicate that different factors influence stable inheritance of endogenous chromosome III and the CF. One explanation is that the telocentric structure of the CF may enhance instability in some mutants. Another is that the presence of a partial homologous chromosome may suppress instability. Further work will be required to determine the underlying biological mechanisms that explain these uncorrelated phenotypes.
Many Yeast CIN Genes Are Conserved. Current understanding of mechanisms that contribute to genome stability has been largely fueled by work from model systems. This approach has been informative for human biology because of remarkable functional conservation within the chromosome cycle. To evaluate conservation of yeast CIN genes, BLASTp searches using yeast amino acid sequences against proteomes from Schizosaccharomyces pombe, Caenorhabditis elegans, Drosophila melanogaster, Mus musculus, and Homo sapiens were performed. Among the 293 yeast CIN genes,
(35%) had homologs with e-values Յ10
Ϫ10 in all five organisms searched. SI Table 7 contains alignment results and links to functional summaries. Previously published work showed that Ϸ40% of yeast proteins are conserved in eukaryotic evolution (47) , and 30% of known genes involved in human disease have yeast homologs (48 (Table 2 and SI Table 8 ).
Discussion
This work identified an extensive catalog of genome instability mutants based on phenotype tests of haploid and diploid yeast knockout collections for CTF, elevated ALF frequency, and BiM behavior. Nonessential yeast genes were characterized because of their accessibility for phenotyping. Because many essential genes are known to contribute to genome stability from traditional approaches, a similar systematic screening effort for these genes would be of great interest but will first require the development of a comprehensive hypomorphic mutation resource.
An extensive catalog is useful for understanding mechanisms that maintain or alter genome structure, for the identification of new pathways important for genome maintenance, and for the organization of functional networks. Systematic screening of arrayed nonessential mutants avoids the sampling problem in traditional mutagenesis methods, and supports the direct comparison of phenotypes observed because all alleles are null. As examples, ALF frequency is shown as fold over wild-type. Event percentages (chr III loss, gross chromosome rearrangement (GCR), or retention of normal structure) are calculated from independent wild-type or mutant mated products (n ϭ 40 and n Ն 10, respectively). The outcome distributions for sov1⌬ and rad27⌬ are significantly different from wild type ( 2 , P Ͻ 0.01). The protein sequences corresponding to 130 high-confidence yeast CIN genes were used as queries in a BLASTP search against the human RefSeq protein database. Online Mendelian Inheritance in Man (OMIM; www.ncbi.nlm.nih.gov/omim) and cancer census (CC; ref. 58) databases were used to identify cancer associated mutations in "top hit" human genes.
rad27⌬, dia2⌬, nce4⌬, and xrs2⌬ exhibited the strongest ALF phenotypes (Ͼ56-fold above wild type) among the high confidence yeast CIN genes, whereas well-studied damage response genes such as mec3⌬, mrc1⌬, ddc1⌬, and rad9⌬ showed milder phenotypes (Ϸ11-fold). Apparently, under the growth conditions used in the screen, damage caused by absence of Rad27, Dia2, Nce4, or Xrs2 proteins exceeds that resulting from checkpoint loss. In addition to phenotype comparisons within a given assay, results from different assays can be compared. For example, xrs2⌬ exhibited one of the highest ALF frequencies but a mild or absent CTF phenotype, indicating that the damage associated with xrs2⌬ is more relevant to the maintenance of a haploid chromosome III than to the artificial CF. In general terms, different chromosome marker stability assays (CTF, ALF, and BiM) defined both distinct and overlapping gene sets. The screen specificities likely reflect functional distinctions revealed by the assay systems and deserve further study as indicators of in vivo roles played by genes that safeguard genome structure.
The errors observed in the deletion arrays underscore the importance of mutant validation. It is widely known that mutant arrays accumulate change because of manipulation and selective pressure (i.e., cross-well contamination, aneuploidy, second site mutation, etc.), but parameters indicative of array quality are under-reported in published studies. This issue is increasingly important as phenotypic data derived from distantly related replicates of the deletion resource are compared and integrated. In this study, tag sequence analysis of CIN mutant strains suggests false negative observations from well contamination were between 9 and 22% in different screens (details in SI Table 3 ). An empirical measure agrees: the CTF screen of the knockout collection identified 12 of 15 nonessential ctf mutants found previously in a traditional mutagenesis (18) . We can also estimate the false positive phenotype detection frequency because of secondary mutations in the deletion collection strains. For the haploid collections, the overall false positive rates were relatively high (Ϸ18% and 31% for the MATa and MAT␣ collections, respectively). For the diploid collection, the false positive rate was lower (Ϸ5%). These frequencies are consistent with observation of unlinked recessive lethal mutations segregating independently of the deletion mutations created during construction of the mutant resource (24) . In this study, false-positive observations were rare among genes identified in more than one marker loss assay (and therefore by mutants in more than one deletion resource), emphasizing the validation that is inherent in screening more than one collection for a mutant phenotype. We therefore partitioned our results into 130 high confidence genes (115 genes identified by more than one screen, plus 15 genes confirmed in new transformants), and 163 lower confidence genes identified by single screens only. Our data indicate that the lower confidence gene set contains many true positive observations, which we roughly estimate as Ϸ33% and 75% of the lower confidence haploid and diploid knockouts, respectively.
A full catalog of yeast CIN genes will provide a rich resource for studies of genomic instability in many organisms, including human. Inclusion of additional screens of nonessential yeast mutants (e.g., refs. 21 and 22) and systematic incorporation of essential mutants will enhance the utility of the yeast model system. Yeast CIN genes define cross-species candidate genes in humans that could be mutated or misregulated during tumorigenesis. A recent survey of CIN colorectal tumors (49) provides a stunning proof of principle. One hundred human candidate genes (chosen for similarity to yeast and fly CIN genes) were screened for mutations in a panel of colorectal tumor samples. This study identified five human CIN genes mutated in cancer (hMRE11, hZW10, hZwilch, hRod, and hDing) adding to two previously known (hCDC4 and hBub1; reviewed in ref. 50) . These seven CIN genes account for Ͻ20% of the CIN mutational spectrum in colon cancer, and many other candidate CIN genes remain untested. Indeed, 103 human homologs of yeast CIN genes (based in part on this work) were tested for somatic mutations in a panel of colorectal cancer samples, identifying eight human CIN genes mutated in colon cancer (K.W.Y.Y., T. Barber, M. Reis, K. McManus, F.A.S., B. Vogelstein, V. Velculescu, P.H., and C. Lengauer, unpublished results). These studies demonstrate that systematic analysis of the mutational spectrum leading to a CIN phenotype in a model organism such as yeast will help to define the mutational spectrum leading to a CIN phenotype in human cancer and may accelerate the development of effective cancer therapies.
Knowledge of the mutational spectrum of CIN genes in human cancer has several important practical implications. In particular, if a defined subset of CIN genes represents the major mutational target in a specific tumor type, the spectrum of mutations might provide a rationale for therapeutic design. The specific class of mutations causing CIN may define a genetic ''Achilles heel'' that would provide selective killing of tumor cells relative to adjacent normal cells. In this strategy, genetic interactions resulting in cell lethality may be useful for the design of therapeutic approaches where the altered genotype of a cancer cell is used to leverage its specific vulnerability. One kind of genetic interaction with properties useful for this strategy is synthetic lethality, observed when two mutations individually capable of supporting viability cause cell death when present together. Synthetic lethal mutant pairs identify genes that function in parallel or related pathways that cannot be simultaneously lost. Following this logic, cancer cells with a specific CIN mutation can be killed through loss of function of a synthetic lethal partner, while sparing normal cells (51, 52) . Large-scale, systematic synthetic lethality analysis in yeast provides a means for identifying such second-site loss of function mutations (53) (54) (55) . The budding yeast studies suggest candidate human proteins whose inhibition (e.g., by a drug) may specifically kill tumor cells relative to normal cells. In this regard, gene deletions that exhibit synthetic lethality with multiple different CIN gene mutants are particularly attractive, as they might define broad-spectrum therapeutic targets.
To address this concept, we analyzed all known synthetic lethal interactions available for yeast CIN genes from Table 2 . Eight of the 10 genes had published synthetic lethal data. The corresponding eight deletion mutations were connected to 250 partners by 371 synthetic lethal interactions based on BioGrid (56) (data not shown). Among the 250 partners, 61 bridged at least two yeast cancer homologs (Fig. 4) . Notably, three mutants exhibited synthetic lethality, with at least six cancer gene homologs. Interestingly, these three yeast genes share a role in sister chromatid cohesion (42, 57) . The ''hub'' position of these three mutants in the interaction network represents a common set of genetic vulnerabilities that may suggest broad spectrum targets.
The extant synthetic lethal data set in budding yeast is continuously expanding (53) , and more ''common nodes'' may be identified. Combining these data with an increased understanding of the mutation spectrum in cancers could provide insights central to the design of therapeutic approaches in which human cancer cells are efficiently targeted for death by clinical intervention. Integration of knowledge among emerging high throughput data sets in model organisms will stimulate new research directions and solutions to challenges in combating human disease.
Materials and Methods
Yeast Strains. Complete genotypes are given in SI Table 9 . Bimater Screen. A homozygous diploid deletion set obtained from Open Biosystems (www.openbiosystems.com) in 96-array format was used. Histidine prototrophs were selected by replica plating mutants exposed to MATa his1 and MAT␣ his1 tester strains on solid medium lacking histidine. Mutants with elevated mating frequency detected with both testers were scored as BiM. Details are provided in SI Fig. 6 .
a-Like Faker Screen. The presence of a-type mating cells in strains from the MAT␣ haploid knockout collection was detected as described (42) . A deletion collection obtained from Research Genetics (MAT␣ his3) was manually arrayed in 1-cm 2 patches and mated to a MATa his1 tester lawn by replica plating. His ϩ prototrophs were selected on synthetic complete medium lacking histidine, uracil, lysine, adenine, tryptophan, and leucine. Details are provided in SI Fig. 7 .
Electrophoretic Karyotypes. Sample preparation, pulsed field gel analysis, and in-gel hybridizations were performed as described (42) .
